OKUR Stock Analysis: Buy, Sell, or Hold?

OKUR - OnKure Therapeutics, Inc. Class A Common Stock

PHARMACEUTICAL PREPARATIONS
$2.64
-0.09 (-3.30%) ▼
HOLD
LOW Confidence
Protect Your OKUR Gains
Last Updated: January 30, 2026
Earnings: Mar 09, 2026

Get Alerted When OKUR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: OKUR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

In-depth Analysis How we analyze

Valuation Analysis: OKUR is currently trading at $2.64, which is considered oversold relative to its 30-day fair value range of $2.76 to $3.05.

Technical Outlook: Technically, OKUR is showing support break momentum. The price is currently testing key support at $2.66. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $27.00 (+889.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $2.76 - $3.05
Company Quality Score 41/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 77.4%

Protect Your Profits

Holding OKUR? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.3%)
  • BULLISH: Trading 889.0% below Wall St target ($27.00)
  • CAUTION: Recommendation downgraded due to -9.9% 5-day decline

Fair Price Analysis

30-Day Fair Range $2.76 - $3.05
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $2.66
Resistance Level $3.21
Current Trend Support Break

Fundamental Context

Forward P/E (Next Year Est.) -0.73
Wall Street Target $27.00 (+889.0%)
Last updated: January 31, 2026 9:43 AM ET
Data refreshes hourly during market hours. Next update: 10:43 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Jason A Leverone SELL 303 shares 2025-09-22
Nicholas A Saccomano SELL 88 shares 2025-09-22

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
29 analysts
$91 59 HOLD
NTLA
Intellia Therapeutics Inc
STRONG BUY
29 analysts
$22 60 HOLD
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$83 57 HOLD
KYMR
Kymera Therapeutics Inc
STRONG BUY
20 analysts
$117 59 HOLD
BNTX
BioNTech SE
STRONG BUY
21 analysts
$141 59 HOLD

Advanced OKUR Option Strategies

Professional options setups generated by AI based on today's OKUR price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for OKUR

OKUR Technical Chart OKUR Price Prediction OKUR Earnings Date OKUR Investment Advisor OKUR Fair Price Analyzer OKUR Options Advisor OKUR Options Chain OKUR Options Analysis OKUR Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals